Urological Devices – Market Insights – Latin America

Driven by the increasing prevalence of urethral stones, aging population, product innovation, and patient awareness of urological treatments in this region, the Latin American urological device market will continue to expand through 2033. Furthermore, favorable demographic trends, an increasing prevalence of BPH and prostate cancer cases, declining ASPs supporting the adoption among budget constraint facilities, and increasing patient awareness and physician training will support urological procedure volume growth. Moreover, the rising trend for minimally invasive procedures, as these techniques not only provide improved efficacy but also reduced postoperative pain and shorter recovery periods, will result in increased adoption of associated devices.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for urological devices in Latin America from 2019 through 2033.

The Latin American urological device market is set to grow over the forecast period.

How will procedure trends affect the market growth?

How are different segments expected to grow over the forecast period?

Post-sale services and product support are increasingly important to Latin American customers when negotiating purchases of urological devices.

What other strategies are competitors using to set themselves apart in the Latin American market?

Economic constraints across Latin America have influenced purchasing decisions among health care facilities.

How will budgetary restrictions influence the urological device market?

How does rampant economic burden affect access to urological treatment?

UI device segment represents a significant proportion of overall market revenues.

What factors impact the use of UI devices?

How will ASPs of UI devices change over the forecast period?